dr. M.M.A. Kip (Michelle)

Dr. Michelle Kip has received her PhD (cum laude) from the University of Twente, Enschede, the Netherlands, in April 2018. Her thesis was entitled: "Early Health Technology Assessment of Point-of-Care and Laboratory Diagnostics". Currently, she works as a postdoctoral researcher at the Health Technology & Services Research Department at the University of Twente. She is experienced in the field of (early) Health Technology Assessment, and her research focuses on methods to evaluate the health economic impact of medical technologies in several phases of development, using cost-effectiveness analysis and simulation modeling. Besides evaluating the health economic impact of medical technologies, she is also experienced in the field of Multi-Criteria Decision Analysis, which includes methods to evaluate stakeholders’ preferences with regard to (new) medical technologies, as well as in expert elicitation.

During her postdoc, Michelle will work on the UCAN CAN-DU project, which aims to develop a biomarker based predictive testing approach to optimize clinical management in juvenile idiopathic arthritis compared to current standard of practice. Within this project, she will be involved in quantifying the impact of (personalized treatment strategies for) juvenile idiopathic arthritis in terms of costs and health outcomes.

Medicine & Life Sciences

# Cost-Benefit Analysis
# Costs And Cost Analysis
# Juvenile Arthritis
# Point-Of-Care Systems
# Quality-Adjusted Life Years

Social Sciences

# Costs
# Diagnostic Laboratory
# Health Economics

Faculty of Behavioural, Management and Social Sciences (BMS), Health Technology & Services Research (HTSR)

van Til, J. A. , Kip, M. M. A., Schatorjé, E. J. H., Currie, G., Twilt, M., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N., Yeung, R. S. M. , Groothuis-Oudshoorn, C. G. M. K., Warta, S., Marshall, D. A. , IJzerman, M. J., & UCAN CAN-DU, UCAN CURE consortia (2023). Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists? Pediatric rheumatology online journal, 21(1), 69. Article 69. Advance online publication. https://doi.org/10.1186/s12969-023-00845-4

Currie, G. R. , Groothuis-Oudshoorn, C. G. M., Twilt, M. , Kip, M. M. A. , IJzerman, M. J., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R., & Marshall, D. A. (2023). What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling survey. Clinical rheumatology, 42(8), 2173-2180. Advance online publication. https://doi.org/10.1007/s10067-023-06616-6

Heerink, J. S., Nies, J. , Koffijberg, H., Oudega, R. , Kip, M. M. A. , & Kusters, R. (2023). Two point-of-care test-based approaches for the exclusion of deep vein thrombosis in general practice: a cost-effectiveness analysis. BMC Primary Care, 24(1), Article 42. Advance online publication. https://doi.org/10.1186/s12875-023-01992-z

Kip, M. M. A., de Roock, S., Currie, G., Marshall, D. A., Grazziotin, L. R., Twilt, M., Yeung, R. S. M., Benseler, S. M., Vastert, S. J., Wulffraat, N., Swart, J. F. , & IJzerman, M. J. (2023). Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: A real-world data analysis. Rheumatology, 62(SI2), SI170-SI180. Advance online publication. https://doi.org/10.1093/rheumatology/keac299

Lingervelder, D. , Kip, M. M. A., Wiese, E. D. , Koffijberg, H. , Ijzerman, M. J. , & Kusters, R. (2022). The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact. BMC health services research, 22(1), Article 1529. https://doi.org/10.1186/s12913-022-08782-w

Wolkorte, R., Heesink, L. , & Kip, M. M. A. (2022). As open as possible, as closed as necessary: how to find the right balance in sharing citizen science data for health? Proceedings of Science, 418, Article 028. https://pos.sissa.it/418/028/pdf

Grazziotin, L. R., Currie, G., Twilt, M. , IJzerman, M. J. , Kip, M. M. A. , Koffijberg, H., Bonsel, G., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R. S. M., Armbrust, W., van den Berg, J. M., & Marshall, D. A. (2022). Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis. Pediatric Rheumatology, 20(1), 1-12. Article 51. Advance online publication. https://doi.org/10.1186/s12969-022-00713-7

Kip, M. M. A., de Roock, S., van den Berg, I., Currie, G., Marshall, D. A., Grazziotin, L. R., Twilt, M., Yeung, R. S. M., Benseler, S. M., Vastert, S. J., Wulffraat, N., Swart, J. F. , & IJzerman, M. J. (2022). Costs of Hospital-Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System. Arthritis Care and Research, 74(10), 1585-1592. Advance online publication. https://doi.org/10.1002/acr.24621

Grazziotin, L. R., Currie, G., Twilt, M. , Ijzerman, M. J. , Kip, M. M. A. , Koffijberg, H., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R. S. M., & Marshall, D. A. (2022). Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study. Pediatric Rheumatology, 20(1), Article 25. https://doi.org/10.1186/s12969-022-00682-x

Currie, G. R., Pham, T., Twilt, M. , IJzerman, M. J., Hull, P. M. , Kip, M. M. A., Benseler, S. M., Hazlewood, G. S., Yeung, R. S. M., Wulffraat, N. M., Swart, J. F., Vastert, S. J., & Marshall, D. A. (2022). Perspectives of Pediatric Rheumatologists on Initiating and Tapering Biologics in Patients with Juvenile Idiopathic Arthritis: A Formative Qualitative Study. The Patient, 15(5), 599-609. Advance online publication. https://doi.org/10.1007/s40271-022-00575-x

Bekijk alle publicaties van deze medewerker

Vakken in het huidig collegejaar worden toegevoegd op het moment dat zij definitief zijn in het Osiris systeem. Daarom kan het zijn dat de lijst nog niet compleet is voor het gehele collegejaar.